Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral misoprostol 100 micrograms versus 50 micrograms for labor induction in obese term and post-term pregnancies
IRCT20250811066824N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of misoprostol in induced labor (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Duration of labor, Rate of successful vaginal delivery and 3 more. Started Sep 2025; status: completed.
02
Drugs
misoprostol
03
Conditions
induced labor
Beyond the preview
Go deeper on IRCT20250811066824N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250811066824N1.